Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | $132.49B | 32.7x | 1.61 | $273.72 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | $6.53B | 23.7x | 3.8 | $33.83 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | $3.82B | -1,210x | 10.63 | $2.42 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.6% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | $1.60B | 13.7x | 0.16 | $12.43 | -9.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | $660.80M | 18.4x | 1.03 | $13.16 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | $563.41M | -34.4x | 2.55 | $0.31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mayne Pharma | Sydney | Healthcare | Pharmaceuticals | $338.39M | -1.8x | 0.01 | $4.18 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.9% Upside | Upgrade to Pro+ | |
AFT Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | $232.80M | 16.5x | 0.35 | $2.22 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biome Australia | Sydney | Healthcare | Pharmaceuticals | $133.66M | -85.9x | -1.79 | $0.56 | -8.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.3% Upside | Upgrade to Pro+ | |
Vita Life Sciences | Sydney | Healthcare | Pharmaceuticals | $116M | 11.9x | 0.46 | $2.06 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recce | Sydney | Healthcare | Pharmaceuticals | $106.66M | -4.6x | 0.2 | $0.47 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Sydney | Healthcare | Pharmaceuticals | $92.46M | -9.1x | 1.58 | $0.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Pharmaceuticals | $60.42M | -2.8x | -0.5 | $0.04 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Radiopharm Theranostics | Sydney | Healthcare | Pharmaceuticals | $56.50M | -0.2x | 0.14 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vitura Health | Sydney | Healthcare | Pharmaceuticals | $56.44M | 14.1x | -0.21 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inoviq | Sydney | Healthcare | Pharmaceuticals | $49.63M | -6.2x | -0.27 | $0.44 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Starpharma Holdings | Sydney | Healthcare | Pharmaceuticals | $48M | -5.8x | -0.11 | $0.12 | 9.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medical Developments | Sydney | Healthcare | Pharmaceuticals | $47.88M | -0.9x | 0 | $0.43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Next Science | Sydney | Healthcare | Pharmaceuticals | $39.44M | -2.7x | -0.07 | $0.14 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Little Green Pharma | Sydney | Healthcare | Pharmaceuticals | $39.23M | -3.7x | -0.18 | $0.13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.8% Upside | Upgrade to Pro+ | |
Oncosil Medical Ltd | Sydney | Healthcare | Pharmaceuticals | $35.87M | -1.6x | -0.07 | $0.007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Pharmaceuticals | $20.96M | -6.1x | -0.2 | $0.10 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Althea | Sydney | Healthcare | Pharmaceuticals | $20.31M | -0.5x | 0.01 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Calmer Co International | Sydney | Healthcare | Pharmaceuticals | $17.61M | -2.7x | -0.06 | $0.008 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immuron Ltd | Sydney | Healthcare | Pharmaceuticals | $17.19M | -2.5x | 0.03 | $0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acrux | Sydney | Healthcare | Pharmaceuticals | $13.08M | -2.3x | 0 | $0.05 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argent BioPharma | Sydney | Healthcare | Pharmaceuticals | $12.48M | -0.5x | -0.01 | $0.23 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Firebrick Pharma | Sydney | Healthcare | Pharmaceuticals | $11.35M | -10.1x | -0.13 | $0.05 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anatara Lifesciences Ltd | Sydney | Healthcare | Pharmaceuticals | $11.19M | -5.8x | -0.15 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Epsilon Healthcare | Sydney | Healthcare | Pharmaceuticals | $7.21M | -1x | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |